Health IT Analytics August 27, 2020
Researchers leveraged genetic testing and precision medicine to reduce the number of adverse events following heart disease treatment.
An international trial used genetic testing and precision medicine techniques to choose antiplatelet therapies for heart disease patients, lowering the chance of heart attack or stroke by 34 percent, according to a study published in JAMA.
Percutaneous coronary intervention (PCI) is a non-surgical procedure where physicians inflate a balloon and place a metal stent in narrowed heart arteries to improve blood flow to the heart. Placement of a balloon and metal stent inside a heart artery can irritate the blood vessel and cause it to clot, which can block the artery from being treated.
PCI patients are prescribed medications to stop their...
Today's Sponsors
Today's Sponsor